RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+9.94%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$928M
AUM Growth
+$928M
Cap. Flow
-$37.6M
Cap. Flow %
-4.05%
Top 10 Hldgs %
57.36%
Holding
71
New
15
Increased
6
Reduced
13
Closed
13

Top Buys

1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
$102M
2
COLL icon
Collegium Pharmaceutical
COLL
$27.6M
3
ARDX icon
Ardelyx
ARDX
$27.5M
4
BPMC
Blueprint Medicines
BPMC
$23.3M
5
MDCO
Medicines Co
MDCO
$20.2M

Top Sells

1
BCRX icon
BioCryst Pharmaceuticals
BCRX
$64.5M
2
ABUS icon
Arbutus Biopharma
ABUS
$47.4M
3
DVAX icon
Dynavax Technologies
DVAX
$43M
4
DYAX
DYAX CORPORATION
DYAX
$39.9M
5
LRMR icon
Larimar Therapeutics
LRMR
$29M

Sector Composition

1 Healthcare 81.38%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AGRX
26
DELISTED
Agile Therapeutics, Inc
AGRX
$12.5M 1.26%
1,458,792
– –
ALPN
27
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$11.5M 1.15%
+757,263
New +$11.5M
MCRB icon
28
Seres Therapeutics
MCRB
$162M
$10.2M 1.03%
+246,645
New +$10.2M
ARCT icon
29
Arcturus Therapeutics
ARCT
$467M
$9.98M 1%
+1,525,894
New +$9.98M
CNCE
30
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$9.95M 1%
668,406
+8,406
+1% +$125K
TENX icon
31
Tenax Therapeutics
TENX
$27.5M
$9.85M 0.99%
2,670,300
– –
SCMP
32
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$7.39M 0.74%
450,000
– –
ORKA
33
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
$6.53M 0.66%
+5,678,592
New +$6.53M
CYTO
34
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
$4.57M 0.46%
940,000
– –
AUPH icon
35
Aurinia Pharmaceuticals
AUPH
$1.58B
$3.45M 0.35%
1,142,676
-362,100
-24% -$1.09M
TRVN
36
DELISTED
Trevena, Inc.
TRVN
$3.31M 0.33%
528,118
-797,289
-60% -$4.99M
TTOO
37
DELISTED
T2 Biosystems, Inc
TTOO
$2.24M 0.23%
138,002
– –
FRTX
38
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1.83M 0.18%
2,606,978
-4,417,296
-63% -$3.09M
VXRT
39
DELISTED
Vaxart
VXRT
$1.67M 0.17%
807,855
-595,998
-42% -$1.23M
MACK
40
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.44M 0.14%
116,400
– –
TSRO
41
DELISTED
TESARO, Inc.
TSRO
$1.38M 0.14%
23,500
– –
LUMO
42
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.33M 0.13%
30,000
– –
REGN icon
43
Regeneron Pharmaceuticals
REGN
$59.8B
$1.25M 0.13%
2,450
– –
PTCT icon
44
PTC Therapeutics
PTCT
$4.41B
$1.24M 0.12%
25,800
– –
ALKS icon
45
Alkermes
ALKS
$4.95B
$1.24M 0.12%
19,200
– –
NBIX icon
46
Neurocrine Biosciences
NBIX
$13.5B
$1.17M 0.12%
+24,400
New +$1.17M
CLVS
47
DELISTED
Clovis Oncology, Inc.
CLVS
$1.16M 0.12%
+13,200
New +$1.16M
ACAD icon
48
Acadia Pharmaceuticals
ACAD
$4.34B
$1.14M 0.12%
27,300
– –
INCY icon
49
Incyte
INCY
$17B
$1.12M 0.11%
+10,700
New +$1.12M
AGIO icon
50
Agios Pharmaceuticals
AGIO
$2.36B
$1.1M 0.11%
9,900
-7,700
-44% -$856K
1
2
3